We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.645
Bid: 1.52
Ask: 1.77
Change: 0.00 (0.00%)
Spread: 0.25 (16.447%)
Open: 1.645
High: 1.645
Low: 1.645
Prev. Close: 1.645
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to the Specialist Fund Segment

26 Mar 2018 08:05

RNS Number : 8278I
Life Settlement Assets PLC
26 March 2018
 

 

Life Settlement Assets PLC

LEI: 2138003OL2VBXWG1BZ27

(the "Company" or "LSA") 

Admission to the Specialist Fund Segment

 

 

The directors of LSA are pleased to announce that the Company's entire issued share capital comprising 45,446,946 A Ordinary Shares of $0.01 each, 14,596,098 B Ordinary Shares of $0.01 each, 9,292,561 D Ordinary Shares of $0.01 each and 1,733,269 E Ordinary Shares of $0.01 each has been admitted to the Specialist Fund Segment of the London Stock Exchange ("Admission") at 8.00 a.m. today. Each Share carries the same voting rights (save in respect of matters relating solely to a specific Share Class), therefore the total number of voting rights in the Company is 71,068,874. Trading in the Predecessor Company's shares on the Luxembourg Stock Exchange was cancelled on 6 March 2018.

 

Shareholders should note that the obligations for shareholders to notify the Company of their shareholding apply at a lower threshold than was the case in Luxembourg. Under Chapter 5 of the Disclosure Guidance and Transparency Rules (the "DTRs"), subject to certain limited expectations, a person must notify the Company (and, at the same time, the FCA) of the percentage of voting rights he holds (within two trading days) if he acquires or disposes of Shares in the Company to which voting rights are attached and if, as a result of the acquisition or disposal, the percentage of voting rights which he holds as a Shareholder (or, in certain cases, which he holds indirectly) or through his direct or indirect holding of certain types of financial instruments (or a combination of such holdings):

 

(a) reaches, exceeds or falls below 3, 4, 5, 6, 7, 8, 9 or 10 per cent. and each 1 per cent threshold thereafter up to 100 per cent; or

(b) reaches, exceeds or falls below an applicable threshold in (a) above as a result of events changing the breakdown of voting rights and on the basis of the total voting rights notified to the market by the Company.

 

Such notification must be made using the prescribed form TR1 available from the FCA's website at http://www.fca.gov.uk. Under the DTRs, the Company must announce the notification to the public as soon as possible and in any event by not later than the end of the trading day following receipt of a notification in relation to voting rights."

 

The Company is a newly established closed-ended investment company whose principal activities are to support and manage portfolios of whole and partial interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company's investment objective is to generate long-term returns for investors by investing in the life settlement market.

 

Acheron Capital Limited ("Acheron") is responsible for devising and modelling the investment strategy of the Company's trusts. Founded in 2006 by Dr. Jean-Michel Paul, Acheron is a London based independent investment manager authorised and regulated by the Financial Conduct Authority that focuses on niche investment strategies uncorrelated to the traditional financial markets.

 

The Company believes that its admission to the Specialist Fund Segment provides it with the ideal platform to enhance the reputation, marketability, liquidity, and valuation of the Company's shares by gaining access to a wider investor audience.

 

The prospectus published by the Company on 30 January 2018 and the supplementary prospectus published by the Company on 23 March 2018 in connection with the Admission can be found on the Company's website www.lsaplc.com, and at the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM.

 

Save for expressions defined in this announcement, words and expressions defined in the Prospectus shall have the same meaning in this announcement.

 

For further information contact

 

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Stockdale Securities Limited (Financial Adviser and Broker)

Robert Finlay / Owen Matthews

020 7601 6115

 

TB Cardew (Financial PR)

Shan Shan Willenbrock

020 7930 0777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXLFLVXFBBBB
Date   Source Headline
1st Mar 20244:13 pmRNSPolicy Maturities
1st Mar 20243:40 pmRNSNet Asset Value(s)
15th Feb 20243:00 pmRNSDividend Declaration
2nd Feb 20244:15 pmRNSNet Asset Value(s)
24th Jan 20249:54 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSPolicy Maturities and update on MBC settlement
13th Dec 202310:35 amRNSHolding(s) in Company
13th Nov 20239:34 amRNSNet Asset Value(s)
17th Oct 20235:14 pmRNSNet Asset Value(s)
27th Sep 20237:00 amRNSHalf-year Report
20th Sep 202311:53 amRNSNet Asset Value(s)
18th Aug 20239:52 amRNSNet Asset Value(s)
17th Jul 20231:06 pmRNSNet Asset Value(s)
14th Jun 20234:14 pmRNSAGM Statement
2nd Jun 202310:17 amRNSNet Asset Value(s)
30th May 202312:33 pmRNSNet Asset Value(s)
16th May 202312:26 pmRNSNet Asset Value(s)
28th Apr 20237:00 amRNSFinal Results
5th Apr 20239:33 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSUpdate on MBC Auction
6th Mar 20233:22 pmRNSHolding(s) in Company
6th Mar 20237:00 amRNSUpdate on MBC Auction
23rd Feb 20233:25 pmRNSNet Asset Value(s)
23rd Feb 20231:56 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDividend Declaration
27th Jan 20234:44 pmRNSUpdate on MBC Auction
16th Jan 202311:40 amRNSNet Asset Value(s)
30th Dec 20227:00 amRNSUpdate on MBC Auction
12th Dec 20227:00 amRNSUpdate on MBC Auction
5th Dec 20222:40 pmRNSStatement re MBC Auction
2nd Dec 20226:21 pmRNSNet Asset Value(s)
14th Nov 202211:24 amRNSNet Asset Value(s)
29th Sep 20223:42 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
8th Sep 20221:32 pmRNSNet Asset Value(s)
10th Aug 202210:09 amRNSNet Asset Value(s)
12th Jul 20225:35 pmRNSHolding(s) in Company
7th Jul 202212:07 pmRNSNet Asset Value(s)
30th Jun 20227:00 amRNSStatement re agreement to reduce performance fee
23rd Jun 20224:22 pmRNSResult of Annual General Meeting
22nd Jun 20224:56 pmRNSNet Asset Value(s)
26th May 202210:56 amRNSNet Asset Value(s)
23rd May 20222:16 pmRNSNet Asset Value(s)
22nd Apr 20227:00 amRNSFinal Results
30th Mar 202210:03 amRNSNet Asset Value(s)
2nd Mar 202211:22 amRNSNet Asset Value(s)
16th Feb 20224:41 pmRNSHolding(s) in Company
19th Jan 20221:05 pmRNSNet Asset Value(s)
21st Dec 202112:08 pmRNSHolding(s) in Company
15th Dec 202110:07 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.